These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 300611)
1. [Role of H-2 region in cytolysis of viral induced lymphomas by T lymphocytes]. Gomard E; Duprez V; Lévy JP Ann Immunol (Paris); 1977; 128(1-2):7-9. PubMed ID: 300611 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice. Lamon EW; Gatti RA; Kiessling R; Fenyö EM Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367 [TBL] [Abstract][Full Text] [Related]
3. Relationships between H-2 and viral antigens in murine oncornavirus-induced tumours. Gomard E; Duprez V; Henin Y; Levy JP J Immunogenet; 1977 Feb; 4(1):35-45. PubMed ID: 192802 [TBL] [Abstract][Full Text] [Related]
4. Cell-medicated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex. Gardner ID; Bowern NA; Blanden RV Eur J Immunol; 1975 Feb; 5(2):122-7. PubMed ID: 1086219 [TBL] [Abstract][Full Text] [Related]
5. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. Weinhold KJ; Wheelock EF Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603 [TBL] [Abstract][Full Text] [Related]
6. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV). Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521 [TBL] [Abstract][Full Text] [Related]
7. Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas. Gomard E; Duprez V; Reme T; Colombani MJ; Levy JP J Exp Med; 1977 Oct; 146(4):909-22. PubMed ID: 197198 [TBL] [Abstract][Full Text] [Related]
8. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998 [TBL] [Abstract][Full Text] [Related]
9. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice. Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741 [TBL] [Abstract][Full Text] [Related]
10. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype. Green WR J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410 [TBL] [Abstract][Full Text] [Related]
11. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL. Stukart MJ; Boes J; Melief CJ J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction. Weiss A; MacDonald HR; Cerottini JC; Brunner KT J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244 [TBL] [Abstract][Full Text] [Related]
13. Lessons from T cell responses to virus induced tumours for cancer eradication in general. Melief CJ; Kast WM Cancer Surv; 1992; 13():81-99. PubMed ID: 1423326 [TBL] [Abstract][Full Text] [Related]
14. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. Flyer DC; Burakoff SJ; Faller DV J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792 [TBL] [Abstract][Full Text] [Related]
15. Immune responses to weakly immunogenic virally induced tumors. III. Genetically unrestricted cytolysis of allogeneic tumor target cells. Devens B; Naor D J Immunol; 1979 Apr; 122(4):1397-401. PubMed ID: 312839 [TBL] [Abstract][Full Text] [Related]
16. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes. Leclerc JC; Cantor H J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332 [TBL] [Abstract][Full Text] [Related]
17. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells. Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454 [TBL] [Abstract][Full Text] [Related]
18. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection. Jiang D; Flyer DC J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885 [TBL] [Abstract][Full Text] [Related]
19. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation. Rembecki RM; Bennett M; Kumar V; Potter TA J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904 [TBL] [Abstract][Full Text] [Related]
20. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants. Byrne JA; Ahmed R; Oldstone MB J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]